Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood

T. A. Fava, R. Desnoyers, S. Schulz, J. Park, D. Weinberg, E. Mitchell, S. A. Waldman

Research output: Contribution to journalArticle

49 Scopus citations

Abstract

Purpose: To examine the utility of guanylyl cyclase C (GC-C)-specific nested reverse transcriptase polymerase chain reaction (RT-PCR) to detect circulating tumor cells in patients with colorectal cancer. Patients and Methods: Peripheral-blood mononuclear cells from 24 patients with Dukes' stage D colorectal cancer were analyzed by GC-C-specific nested RT-PCR using 1 μg of total RNA. Peripheral-blood mononuclear cells from 20 healthy volunteers served as controls. Additionally, peripheral-blood CD34+ progenitor cells were assayed for the expression of both GC-C and other epithelial cell-specific markers. Results: GC-C mRNA was detected in blood mononuclear cells from all 24 patients with colorectal cancer and all healthy volunteers. These unexpected positive results reflected low-level ectopic transcription of GC-C in CD34+ progenitor cells. Moreover, CD34+ progenitor cells expressed other epithelial cell-specific markers, including prostate-specific antigen, prostate-specific membrane antigen, carcinoembryonic antigen, CK-19, CK-20, mucin 1, and GA733.2. Limiting the quantity of mononuclear cell total RNA analyzed to ≤ 0.8 μg eliminated detection of GC-C and other tissue-specific transcripts in blood of healthy volunteers. However, under the same conditions, GC-C mRNA was detected in mononuclear cells from all 24 patients with metastatic colorectal cancer. Using 0.5 μg of total RNA and GC-C-specific primers, nested RT-PCR detected a single human colon carcinoma cell (approximately 20 to 200 GC-C transcripts/cell) in 106 to 107 mononuclear blood cells. Conclusion: These data suggest that GC-C may be useful for detecting circulating colorectal cancer cells. They also demonstrate that CD34+ cells are a source of ectopically expressed epithelial cell-specific markers and that CD34+ cells may contribute to the high false-positive rate generally observed when those markers are used to detect rare circulating metastatic cancer cells by RT-PCR.

Original languageEnglish (US)
Pages (from-to)3951-3959
Number of pages9
JournalJournal of Clinical Oncology
Volume19
Issue number19
DOIs
StatePublished - Oct 1 2001

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Ectopic expression of guanylyl cyclase C in CD34<sup>+</sup> progenitor cells in peripheral blood'. Together they form a unique fingerprint.

  • Cite this

    Fava, T. A., Desnoyers, R., Schulz, S., Park, J., Weinberg, D., Mitchell, E., & Waldman, S. A. (2001). Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood. Journal of Clinical Oncology, 19(19), 3951-3959. https://doi.org/10.1200/JCO.2001.19.19.3951